MAP3K1-IN-1

Overview

MAP3K1-IN-1 is an orally active and selective MAP3K1 kinase inhibitor. MAP3K1-IN-1 blocks TNFα-induced phosphorylation of IKKβ and activation of NF-κB . MAP3K1-IN-1 inhibits the growth of cancer cells. MAP3K1-IN-1 induces a decrease in phosphorylation sites of NPM1 . MAP3K1-IN-1 can be used in pancreatic cancer-related research.

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pancreatic Cancer | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > NF-κB | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > MAP3K | Products > Signaling Pathways > IKK | Products > Signaling Pathways > NF-κB

Product Information

• Catalog No.: HY-208723
• CAS No.: 2345648-39-5
• Molecular Formula: C20H14F4N6O
• Molecular Weight: 430.36
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source